Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence

HAYWARD, CALIFORNIA, July 29, 2025 – (ACN Newswire via SeaPRwire.com) – Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use. The media and chambers were part of Biolog’s acquisition of Anaerobe […]

GTJAI Achieved ‘Carbon Neutrality’ at Operational Level for the Third Consecutive Year

HONG KONG, July 29, 2025 – (ACN Newswire via SeaPRwire.com) – July 25, Guotai Junan International Holdings Limited (“GTJAI” or the “Company”, stock code: 1788.HK), a company of Guotai Haitong Group, is pleased to announce that while actively saving energy and reducing emissions,it has successfully offset its Scope 1 and Scope 2 carbon emissions totaling 609.29 […]

China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer’s Disease Accepted in China

SHENZHEN, CHINA, July 29, 2025 – (ACN Newswire) – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) (“ZUNVEYL” or the “Product”) has been accepted by the National Medical Products Administration of China […]

Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains

HONG KONG, July 29, 2025 – (ACN Newswire via SeaPRwire.com) – On one front, Unitree is accelerating toward an IPO, aiming to become “China’s first publicly listed robotics company.” On the other, Booster Robotics has just secured a historic championship at the RoboCup World Cup. These two Chinese robotics leaders have captured industry and capital market […]

GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases

ANKARA, Turkey, July 28, 2025 – (ACN Newswire via SeaPRwire.com) – GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical company, announced positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class and novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. The findings were presented at the Alzheimer’s […]

GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases

ANKARA, Turkey, July 28, 2025 – (ACN Newswire via SeaPRwire.com) – GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical company, announced positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class and novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. The findings were presented at the Alzheimer’s […]

Doubleview Gold Corp Initiates Advanced Exploration Program at Red Spring, Bolstering Its Critical Minerals Portfolio

Vancouver, British Columbia–(ACN Newswire via SeaPRwire.com – July 28, 2025) – Doubleview Gold Corp (TSXV: DBG) (OTCQB: DBLVF) (WKN: LA1W038) (FSE: 1D4) (“Doubleview” or the “Company”) is pleased to announce the commencement of an advanced exploration program at its 90%-owned copper-silver-zinc-gold Red Spring Project, located in central British Columbia, Canada. This initiative marks a significant step in unlocking […]

Doubleview Gold Corp Initiates Advanced Exploration Program at Red Spring, Bolstering Its Critical Minerals Portfolio

Vancouver, British Columbia–(ACN Newswire via SeaPRwire.com – July 28, 2025) – Doubleview Gold Corp (TSXV: DBG) (OTCQB: DBLVF) (WKN: LA1W038) (FSE: 1D4) (“Doubleview” or the “Company”) is pleased to announce the commencement of an advanced exploration program at its 90%-owned copper-silver-zinc-gold Red Spring Project, located in central British Columbia, Canada. This initiative marks a significant step in unlocking […]

Quantum Solutions Forms Strategic Alliance with TDX Strategies to Advance Bitcoin Treasury Deployment

Tokyo, Japan, July 28, 2025 – (ACN Newswire via SeaPRwire.com) –  Quantum Solutions Co., Ltd. (2338.T) and its affiliates (the “Quantum Solutions’ Group” or “Quantum Solutions”), a Tokyo Stock Exchange-listed company, today announced a new strategic milestone in its digital asset initiative. The Quantum Solutions’ Group, has entered into a business collaboration arrangement with TDX […]

Quantum Solutions Forms Strategic Alliance with TDX Strategies to Advance Bitcoin Treasury Deployment

Tokyo, Japan, July 28, 2025 – (ACN Newswire via SeaPRwire.com) –  Quantum Solutions Co., Ltd. (2338.T) and its affiliates (the “Quantum Solutions’ Group” or “Quantum Solutions”), a Tokyo Stock Exchange-listed company, today announced a new strategic milestone in its digital asset initiative. The Quantum Solutions’ Group, has entered into a business collaboration arrangement with TDX […]

LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma

TOKYO, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its in-house discovered tyrosine kinase inhibitor, “LENVIMA®” (generic name: lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial chemoembolization (TACE) has been approved by the National Medical Products Administration (NMPA) of […]

Đầu Tư Vào 3 Cổ Phiếu Động Lực

(SeaPRwire) –   Đầu tư vào thị trường chứng khoán từ lâu đã là một chiến lược tạo dựng sự giàu có. Một khoản đầu tư được suy nghĩ kỹ lưỡng chỉ 2000 đô la vào đúng cổ phiếu có thể mang lại lợi nhuận đáng kể theo thời gian. Hãy cùng khám phá ba […]